These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21914495)

  • 1. HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.
    Cui XY; Wang N; Yang BX; Gao WF; Lin YM; Yao XR; Ma XT
    Exp Hematol; 2012 Jan; 40(1):14-21. PubMed ID: 21914495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Levels of H11/HspB8 DNA methylation in human melanoma tissues and xenografts are a critical molecular marker for 5-Aza-2'-deoxycytidine therapy.
    Smith CC; Li B; Liu J; Lee KS; Aurelian L
    Cancer Invest; 2011 Jul; 29(6):383-95. PubMed ID: 21649464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
    Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth.
    Liu Y; Howard D; Rector K; Swiderski C; Brandon J; Schook L; Mehta J; Bryson JS; Bondada S; Liang Y
    PLoS One; 2012; 7(9):e44979. PubMed ID: 23028717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methylation of Id4 gene promoter in 4 malignant hematopoietic cell lines].
    Zhao Y; Wang QS; Li HH; Jing Y; Bo J; Wang SH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1418-20. PubMed ID: 19099656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies.
    Nagai H; Li Y; Hatano S; Toshihito O; Yuge M; Ito E; Utsumi M; Saito H; Kinoshita T
    Genes Chromosomes Cancer; 2003 Sep; 38(1):13-21. PubMed ID: 12874782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth and gene expression of leukemia cell after treated with methylation inhibitor 5-aza-2'-deoxycytidine].
    Qiao SK; Xu SR; Guo XN
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):486-90. PubMed ID: 15555266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mda-7/IL-24 inhibits the proliferation of hematopoietic malignancies in vitro and in vivo.
    Dong CY; Zhang F; Duan YJ; Yang BX; Lin YM; Ma XT
    Exp Hematol; 2008 Aug; 36(8):938-46. PubMed ID: 18468766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
    Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
    Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of PLCD1 in chronic myeloid leukemia.
    Song JJ; Liu Q; Li Y; Yang ZS; Yang L; Xiang TX; Ren GS; Chen JB
    Int J Mol Med; 2012 Jul; 30(1):179-84. PubMed ID: 22576628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPX3 promoter is methylated in chronic myeloid leukemia.
    Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J
    Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation.
    Uchida E; Suwa S; Yoshimoto R; Watanabe K; Kasama T; Miura O; Fukuda T
    Int J Oncol; 2019 May; 54(5):1785-1796. PubMed ID: 30864683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
    Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation silencing of the Apaf-1 gene in acute leukemia.
    Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
    Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
    Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
    Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
    Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
    Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
    Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of promoter methylation of p16 gene in hematological malignant cell lines by nested methylation specific polymerase chain reaction].
    Zhou HR; Shen JZ; Fu HY; Ye BG; Fan LP; Lin FA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):375-8. PubMed ID: 16638219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.